Curriculum Vitae

PROF. DR. ALIMOHAMMAD SHARIFI

Professor
  • Department of Orthopaedic Surgery
    Faculty of Medicine
  • 79677022 Ext: 2693

BIOGRAPHY


Prof. Ali Mohammad Sharifi is a scholar with over 27 years of experience in Molecular Pharmacology at the Iran University of Medical Sciences and currently joined as a professor of regenerative Medicine in the Tissue Engineering Group at NOCERAL, department of Orthopedics Surgery, School of Medicine. He obtained his Ph.D. from the University of Glasgow in 1992 and in 2018, he further enriched his expertise by acquiring a Tissue Banking Diploma from the National University of Singapore.

Throughout his career, Prof. Sharifi has undertaken international research, including working at McGill University in Canada and at Max Plank Institute in Germany. His research output includes over 100 publications in high-impact journals, along with several patented innovations.

He has held various administrative and editorial roles in academia, and has served as a peer reviewer for numerous high-impact journals. His dedication to education is evident through his mentorship of undergraduate and postgraduate students, particularly Ph.D. candidates specializing in molecular medicine, tissue engineering, molecular pharmacology, and cell therapy. 

Prof. Sharifi's research expertise involves the fields of cell therapy and regenerative Pharmacology, with a particular emphasis on translational medicine. His extensive body of work includes pioneering studies on pharmacological priming, therapeutic angiogenesis, and innovative strategies to enhance the effectiveness of stem cell therapy by manipulating HIF-1α stabilization, especially in the context of diabetes. Additionally, his research activities include bone and cartilage regeneration, employing a diverse array of strategies such as stem cells and biologically derived products like amniotic membrane extract and mesenchymal stem cell-derived secretome. He has also explored the potential of herbal agents in regenerative medicine. 

His contributions extend to the development of custom-made bio-implants for addressing large bone defects and the design and production of various wound dressings, with a specific focus on diabetic wound healing. In recent times, Prof. Sharifi has harnessed the transformative power of CRISPR gene editing technology to combat synovial fibrosis induced by osteoarthritis.

In summary, Professor Sharifi is an active scientist in the field of Molecular Pharmacology and Regenerative Medicine, exemplifying innovation, and dedication to advancing scientific knowledge for improvement of healthcare and human well-being.

 

AREAS OF EXPERTISE


  • REGENERATIVE MEDICINE AND TISSUE ENGINEERING
    Regenerative Medicine, Gene therapy, CRISPR-CAS gene editing
  • BIO-POLYMERS
  • STEM CELL TECHNOLOGY
    Regenerative Medicine, Tissue Engineering, Drug delivery
  • MOLECULAR PHARMACOLOGY
    Regenerative Pharmacology, Regenerative Medicine, Tissue Engineering, Cell therapy, Drug repurposing, Bone and Cartilage regeneration, wound healing, Drug delivery

ACADEMIC QUALIFICATION


  • PhD, (Pharmacology)
    University of Glasgow, Scotland

ADMINISTRATIVE DUTIES


  • Head of Section
    15 Jan 2023 - 31 Dec 2023 (Department)
  • Head of Unit
    04 Mar 2022 - 31 Dec 2022 (Department)

MEMBERSHIPS


  • ASSOCIATE EDITOR OF FRONTIERS IN PHARMACOLOGY/INTERGRATIVE AND REGENERATIVE PHARMACOLOGY, EDITORIAL BOARD
    2020 to 2024 (International)

PUBLICATIONS


Article in Journal
WoS
  1. Bashiri, Zahra; Moghaddaszadeh, Ali; Falak, Reza; Khadivi, Farnaz; Afzali, Azita; Abbasi, Mehdi; Sharifi, Ali Mohammad; Asgari, Hamid Reza; Ghanbari, Farid; Koruji, Morteza (2023). Generation of Haploid Spermatids on Silk Fibroin-Alginate-Laminin-Based Porous 3D Scaffolds, MACROMOLECULAR BIOSCIENCE. . doi:10.1002/mabi.202200574
  2. Gharanizadeh, Kaveh; Sharifi, Ali Mohammad; Tayyebi, Hamed; Heidari, Razieh; Amiri, Shayan; Noorigaravand, Sajad (2023). Core decompression combined with local DFO administration loaded on polylactic glycolic acid scaffolds for the treatment of osteonecrosis of the femoral head: a pilot study, BMC PHARMACOLOGY & TOXICOLOGY. 24(1). doi:10.1186/s40360-023-00682-x
  3. Nour, Shirin; Imani, Rana; Mehrabani, Mehrnaz; Solouk, Atefeh; Iranpour, Maryam; Jalili-Firoozinezhad, Sasan; Sharifi, Ali Mohammad (2023). Biomimetic hybrid scaffold containing niosomal deferoxamine promotes angiogenesis in full-thickness wounds, MATERIALS TODAY CHEMISTRY. 27. doi:10.1016/j.mtchem.2022.101314
  4. Adib, Fatemeh Rastegar; Bagheri, Fatemeh; Sharifi, Ali Mohammad (2022). Osteochondral regeneration in rabbit using xenograft decellularized ECM in combination with different biological products; platelet-rich fibrin, amniotic membrane extract, and mesenchymal stromal cells, JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS. . doi:10.1002/jbm.b.35063
  5. Nour, Shirin; Imani, Rana; Shari, Ali Mohammad (2022). Angiogenic Effect of a Nanoniosomal Deferoxamine-Loaded Poly(vinyl alcohol)-Egg White Film as a Promising Wound Dressing, ACS BIOMATERIALS SCIENCE & ENGINEERING. 8(8), 3485-3497. doi:10.1021/acsbiomaterials.2c00046
  6. Oustadi, Fereshteh; Imani, Rana; Nazarpak, Masoumeh Haghbin; Sharifi, Ali Mohammad; McInnes, Steven J. P. (2022). Nanofiber/hydrogel composite scaffold incorporated by silicon nanoparticles for sustained delivery of osteogenic factor: in vitro study, INTERNATIONAL JOURNAL OF POLYMERIC MATERIALS AND POLYMERIC BIOMATERIALS. . doi:10.1080/00914037.2022.2147176
  7. Darvishi, B., Dinarvand, R., Mohammadpour, H., Kamarul, T., & Sharifi, A. M. (2021). Dual L-Carnosine/Aloe vera Nanophytosomes with Synergistically Enhanced Protective Effects against Methylglyoxal-Induced Angiogenesis Impairment. Molecular Pharmaceutics, 18(9), 3302-3325. doi: 10.1021/acs.molpharmaceut.1c00248
  8. Mirmajidi, T., Chogan, F., Rezayan, A. H., & Sharifi, A. M. (2021). In vitro and in vivo evaluation of a nanofiber wound dressing loaded with melatonin. International Journal of Pharmaceutics, 596, 14. doi: 10.1016/j.ijpharm.2021.120213
  9. Naderi Gharehgheshlagh, Soheila; Fatemi, Mohammad Javad; Jamili, Shahla; Nourani, Mohammad Reza; Sharifi, Ali Mohammad; Saberi, Mohsen; Amini, Naser; Ganji, Fatemeh (2021). A Dermal Gel Made ofRutilus KutumSkin Collagen-Chitosan for Deep Burn Healing, INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS. 27(1), 317-328. doi:10.1007/s10989-020-10082-y
  10. Nour, S., Imani, R., Chaudhry, G. R., & Sharifi, A. M. (2021). Skin wound healing assisted by angiogenic targeted tissue engineering: A comprehensive review of bioengineered approaches. Journal of Biomedical Materials Research Part A, 109(4), 453-478. doi: 10.1002/jbm.a.37105
  11. Chogan, Faraz; Mirmajidi, Tahereh; Rezayan, Ali Hossein; Sharifi, Ali Mohammad; Ghahary, Aziz; Nourmohammadi, Jhamak; Kamali, Amir; Rahaie, Mahdi (2020). Design, fabrication, and optimization of a dual function three-layer scaffold for controlled release of metformin hydrochloride to alleviate fibrosis and accelerate wound healing, ACTA BIOMATERIALIA. 113, 144-163. doi:10.1016/j.actbio.2020.06.031
  12. Gharagheshlagh, S. N., Fatemi, M. J., Jamili, S., Sharifi, A. M., Nourani, M. R. (2020). Isolation and characterization of acid-soluble collagen from the skin of Rutilus Frisii Kutum (Kamensky) of the Caspian Sea. Iranian Journal of Fisheries Sciences, 19(2), 768-779. doi: 10.22092/ijfs.2019.118957
  13. Nalairndran, G., Razack, A. H. A., Mai, C. W., Chung, F. F. L., Chan, K. K., Hii, L. W., . . . Leong, C. O. (2020). Phosphoinositide-dependent Kinase-1 (PDPK1) regulates serum/glucocorticoid-regulated Kinase 3 (SGK3) for prostate cancer cell survival. Journal of Cellular and Molecular Medicine, 24(20), 12188-12198. doi: 10.1111/jcmm.15876
  14. Hosseinzadeh, A., Juybari, K. B., Kamarul, T., Sharifi, A. M. (2019). Protective effects of atorvastatin on high glucose-induced oxidative stress and mitochondrial apoptotic signaling pathways in cultured chondrocytes. Journal of Physiology and Biochemistry, 75(2), 153-162. doi:10.1007/s13105-019-00666-8
  15. Mehrabani, M., Najafi, M., Kamarul, T., Mansouri, K., Iranpour, M., Nematollahi, M. H., Ghazi-Khansari, M., Sharifi, A. M. (2015). Deferoxamine preconditioning to restore impaired HIF-1-mediated angiogenic mechanisms in adipose-derived stem cells from STZ-induced type 1 diabetic rats, Cell Proliferation. 48(5532-549), Article
  16. Mirzamohammadi, S., Aali, E., Najafi, R., Kamarul, T., Mehrabani, M., Aminzadeh, A., Sharifi, A. M. (2015). Effect of 17 beta-estradiol on mediators involved in mesenchymal stromal cell trafficking in cell therapy of diabetes, Cytotherapy. 17(1), 46-57
ESCI
  1. Tajali, Raziye; Eidi, Akram; Tafti, Hosein Ahmadi; Pazouki, Abdolreza; Kamarul, Tunku; Sharifi, Ali Mohammad (2023). Transplantation of adipose derived stem cells in diabetes mellitus; limitations and achievements, JOURNAL OF DIABETES AND METABOLIC DISORDERS. . doi:10.1007/s40200-023-01280-8
Scopus
  1. Bashiri Z., Moghaddaszadeh A., Falak R., Khadivi F., Afzali A., Abbasi M., Sharifi A.M., Asgari H.R., Ghanbari F., Koruji M. (2023). Generation of Haploid Spermatids on Silk Fibroin-Alginate-Laminin-Based Porous 3D Scaffolds, Macromolecular Bioscience. . doi:10.1002/mabi.202200574
  2. Nour S., Imani R., Mehrabani M., Solouk A., Iranpour M., Jalili-Firoozinezhad S., Sharifi A.M. (2023). Biomimetic hybrid scaffold containing niosomal deferoxamine promotes angiogenesis in full-thickness wounds, Materials Today Chemistry. 27. doi:10.1016/j.mtchem.2022.101314
  3. Safari S., Eidi A., Mehrabani M., Fatemi M.J., Sharifi A.M. (2023). Antioxidant effects of adipose derived stem cells conditioned media against high glucose-induced injuries in cultured of C28I2 chondrocytes, Tehran University Medical Journal. 81(1), 21-28
  4. Sheibani M., Shayan M., Jafari-Sabet M., Sharifi A.M. (2023). Applications of Phytomedicines in Chondrocytes and Osteocytes Regeneration Therapy: Pre-Clinical and Clinical Studies, Traditional and Integrative Medicine. 8(3), 299-315. doi:10.18502/tim.v8i3.13716
  5. Tajali R., Eidi A., Tafti H.A., Pazouki A., Kamarul T., Sharifi A.M. (2023). Transplantation of adipose derived stem cells in diabetes mellitus; limitations and achievements, Journal of Diabetes and Metabolic Disorders. . doi:10.1007/s40200-023-01280-8
  6. Tajali R., Eidi A., Tafti H.A., Pazouki A., Sharifi A.M. (2023). Restoring the Angiogenic Capacity of the Human Diabetic Adipose-derived mesenchymal stem cells Primed with Deferoxamine as a Hypoxia Mimetic Agent: Role of HIF-1 , Advanced Pharmaceutical Bulletin. 13(2), 350-360. doi:10.34172/apb.2023.021
  7. Nour S., Imani R., Sharifi A.M. (2022). Angiogenic Effect of a Nanoniosomal Deferoxamine-Loaded Poly(vinyl alcohol)-Egg White Film as a Promising Wound Dressing, ACS biomaterials science & engineering. 8(8), 3485-3497. doi:10.1021/acsbiomaterials.2c00046
  8. Safari S., Eidi A., Mehrabani M., Fatemi M.J., Sharifi A.M. (2022). Conditioned Medium of Adipose-Derived Mesenchymal Stem Cells as a Promising Candidate to Protect High Glucose-Induced Injury in Cultured C28I2 Chondrocytes, Advanced Pharmaceutical Bulletin. 12(3), 632-640. doi:10.34172/apb.2022.044
  9. Mehrabani, M., Najafi, M., Kamarul, T., Mansouri, K., Iranpour, M., Nematollahi, M. H., Ghazi-Khansari, M., Sharifi, A. M. (2015). Deferoxamine preconditioning to restore impaired HIF-1 -mediated angiogenic mechanisms in adipose-derived stem cells from STZ-induced type 1 diabetic rats, Cell Proliferation. 48(5532-54909607722 (ISSN). )
  10. Mirzamohammadi, S., Aali, E., Najafi, R., Kamarul, T., Mehrabani, M., Aminzadeh, A., Sharifi, A. M. (2015). Effect of 17 -estradiol on mediators involved in mesenchymal stromal cell trafficking in cell therapy of diabetes, Cytotherapy. 17(1), 46-57
Others
  1. Elham Farhadia, Majid Safaa,b, Ali M. Sharific and Davood Bashashd (2016). PRIMA-1 induces caspase-mediated apoptosis in acute promyelocytic leukemia NB4 cells by inhibition of nuclear factor- B and downregulation of Bcl-2, XIAP, and c-Myc Anti-Cancer Drugs. (2016)
  2. Fatemeh Mohabatpour,a Akbar Karkhaneh and Ali Mohammad Sharifi. 2016. A hydrogel/fiber composite scaffold for chondrocyte encapsulation in cartilage tissue regeneration. RSC advances
  3. Mirzamohammadi, S., Mehrabani, M., Tekiyehmaroof, N, Sharifi, A.M.2015.Protective effect of 17 -estradiol on serum deprivation-induced apoptosis and oxidative stress in bone marrow-derived mesenchymal stem cells.Hum Exp Toxicol. 2016 Mar;35(3):312-22
  4. Moshiri, A. Sharifi, A.M., Oryan, A. 2016. Role of Simvastatin on fracture healing and osteoporosis: a systematic review on in vivo investigations. Clin Exp Pharmacol Physiol.
  5. Nikoui V, Ostadhadi S, Azhand P, Zolfaghari S, Amiri S, Foroohandeh M, Motevalian M, Sharifi AM, Bakhtiarian A. The effect of nitrazepam on depression and curiosity in behavioral tests in mice: The role of potassium channels. Eur J Pharmacology 791 (2016) 369-376
  6. Nouri F, Salehinejad P, Nematollahi-Mahani SN, Kamarul T, Zarrindast MR, Sharifi AM. 2016). Deferoxamine Preconditioning of Neural-Like Cells Derived from Human Wharton's Jelly Mesenchymal Stem Cells as a Strategy to Promote Their Tolerance and Therapeutic Potential: An In Vitro Study. Cell Mol. Neurobiology 36(5):689-700
  7. Samira Rayegan , Ahmad Reza Dehpour, Ali Mohammad Sharif (2016). Studying neuroprotective effect of Atorvastatin as a small molecule drug on high glucose-induced neurotoxicity in undifferentiated PC12 cells: role of NADPH oxidase Metab Brain Dis.
  8. Shahriar Mirpour, Somayeh Piroozmand, Neda Soleimani, Neda Jalali Faharani, Hamidreza Ghomi, Hoda Fotovat Eskandari, Ali Mohammad Sharifi, Sahar Mirpour, Mohammad Eftekhari & Maryam Nikkhah. (2016). Utilizing the micron sized nonthermal atmospheric pressure plasma inside the animal body for the tumor treatment application. Sci. Report. 6:29048
  9. Hosseini, A, Sharifi, A.M., Abdollahi, M., Najafi, R, Baeeri. M, Rayegan, S., Cheshmehnour J, Hassani, S., Bayrami, Z., Safa, M. 2015.Cerium and yttrium oxide nanoparticles against lead- induced oxidative stress and apoptosis in rat hippocampus. Biol Trace Elem Res. 164(1):80-9
  10. Mehrabani, M., Najafi, M., Kamarul, T., Mansouri, K, Iranpour, M., Nematollahi, M.H., Ghazi-Khansari, M, Sharifi, A.M. 2015.Deferoxamine preconditioning to restore impaired HIF-1α-mediated angiogenic mechanisms in adipose-derived stem cells from STZ- induced type 1 diabetic rats.Cell Prolif. 48(5):532- 49
  11. Mirzamohammadi, S., Aali, E., Najafi, R., Kamarul, T, Mehrabani, M., Aminzadeh, A., Sharifi, A.M. 2015.Effect of 17β-estradiol on mediators involved in mesenchymal stromal cell trafficking in cell therapy of diabetes. Cytotherapy. 17(1):46-57
  12. Najafi, R., Sharifi, A.M., Hosseini, A. 2015.Protective effects of alpha lipoic acid on high glucose-induced neurotoxicity in PC12 cells. Metab Brain Dis. 30(3):731-8
  13. Nouri,F. Salehinejad,p. Nematollahi-mahani, s.n., kamarul, t., Zarrindast, M.R. Sharifi, A.M. 2015.Deferoxamine Preconditioning of Neural-Like Cells Derived from Human Wharton s Jelly Mesenchymal Stem Cells as a Strategy to Promote Their Tolerance and Therapeutic Potential: An In Vitro Study Cellular and Molecular Neurobiology 1-12
  14. Shakeri-Zadeh, A., Khoei, S., Khoee, S., Sharifi A.M., Shiran, MB.Combination of ultrasound and newly synthesized magnetic nanocapsules affects the temperature profile of CT26 tumors in BALB/c mice.J Med Ultrason (2001). 2015 Jan;42(1):9-16
  15. Sharifi, A.M., Zare, B., Keshavarz, M., Larijani, B. 2015. Urinary N-acetyl- -D-glucosaminidase (NAG) activity in the early detection of diabetic nephropathy. International Journal of Diabetes in Developing Countries. 35(3), 369-374.
  16. Aminzadehو A., Dehpourو A.R., Safaو M., Mirzamohammadi S., Sharifiو A.M. 2014.Investigating the protective effect of lithium against high glucose-induced neurotoxicity in PC12 cells: involvements of ROS, JNK and P38 MAPKs, and apoptotic mitochondria pathway. Cell Mol Neurobiol. 34(8):1143-50
  17. Eslami, H., Sharifi, A.M., Rahimi H, Rahati. 2014.M.Protective effect of telmisartan against oxidative damage induced by high glucose in neuronal PC12 cell.Neurosci Lett. 13;558:31-6.
  18. Shakeri-Zadeh A, Shiran MB, Khoee S, Sharifi AM, Ghaznavi H, Khoei S. 2014.A new magnetic nanocapsule containing 5-fluorouracil: in vivo drug release, anti- tumor, and pro-apoptotic effects on CT26 cells allograft model.J Biomater Appl. 29(4):548-56
  19. Tondar M, Parsa MJ, Yousefpour Y, Sharifi AM, Shetab- Boushehri SV. 2014. Feasibility of clinoptilolite application as a microporous carrier for pH- controlled oral delivery of aspirin. Acta Chim Slov. 61(4):688-93.
  20. Arefi, S., Mottaghi, S., Sharifi, A.M. 2013. Studying the correlation of renin-angiotensin-system (RAS) components and insulin resistance in polycystic ovary syndrome (PCOs).Gynecol Endocrinol. 29(5):470-3
  21. Mohammadzadeh,L., Samedanifard, S.H., Keshavarzi, A., Alimoghaddam, K., Larijani, B., Ghavamzadeh, A., Ahmadi, A.Sl, Shojaeifard A, Ostadali MR, Sharifi, A.M, Amini, M.R., Mahmoudian, A., Fakhraei, H, Aalaa M, Mohajeri-Tehrani MR. 2013.Therapeutic outcomes of transplanting autologous granulocyte colony- stimulating factor-mobilised peripheral mononuclear cells in diabetic patients with critical limb ischaemia.Exp Clin Endocrinol Diabetes. 121(1):48-53
  22. Moshtagh, P.R., Emami, S.H., Sharifi, A.M. 2013.Differentiation of human adipose-derived mesenchymal stem cell into insulin-producing cells: an in vitro study.J Physiol Biochem. 69(3):451-8
  23. Mottaghi,S., Larijani, B., Sharifi, A.M. 2013.Atorvastatin: an efficient step forward in mesenchymal stem cell therapy of diabetic retinopathy.Cytotherapy. 15(3):263-6.
  24. Najafi, R., Sharifi A.M. 2013. Deferoxamine preconditioning potentiates mesenchymal stem cell homing in vitro and in streptozotocin- diabetic rats.Expert Opin Biol Ther. 2013 Jul;13(7):959-72.
  25. Ghodsi M, Heshmat R, Amoli M, Keshtkar AA, Arjmand B, Aghayan H, Hosseini P, Sharifi AM, Larijani B. 2012. The effect of fetal liver-derived cell suspension allotransplantation on patients with diabetes: first year of follow-up. Acta Med Iran. 50(8):541-6
  26. Imani R, Hojjati Emami S, Fakhrzadeh H, Baheiraei N, Sharifi AM.(2012). Optimization and comparison of two different 3D culture methods to prepare cell aggregates as a bioink for organ printing. Biocell. 36(1):37-45.
  27. Mottaghi S, Larijani B, Sharifi AM. Apelin 13: a novel approach to enhance efficacy of hypoxic preconditioned mesenchymal stem cells for cell therapy of diabetes.Med Hypotheses.79(6):717-8

RESEARCH PROJECT


National
  1. 2023 - 2026, Fundamental Research Grant Scheme (FRGS)
    Elucidating The Role And Mechanism Of The Hif-1? On Tgf?/alks/smads Axis In Human Fibroblast Like Synoviocyte To Combat Osteoarthritis Induced Synovial Fibrosis ( Principal Investigator(PI))
  2. 2023 - 2026, Fundamental Research Grant Scheme (FRGS)
    Investigating The Effect And Mechanism Of Amniotic Membrane Extract On Phenotype Switching Of Synovial-myofibroblast Into Fibroblast By Modulating Tgf?/smads/ctgf Pathways In Fibroblast Like Synoviocyte From Oa Patients To Reverse Synovial Fibrosis ( Co-Researcher)

PAPER PRESENTED


INVITED SPEAKER
  1. strategy for enhancing therapeutic efficacy: pharmacological priming in stem cell therapy for impairedangiogenesis disease with empasis on HIF-1a modulation, 5th international and 26th national Iranian congress of physiology and pharmacology, Iranian society of physiology and pharmacology (International) (11 Oct 2023 - 13 Oct 2023)

ACADEMIC/PROF. SERVICES


Evaluation
  1. (2023) Frgs 2023 Evaluation (Fom), University, (Reviewer)
  2. (2022) Evaluation of Master Thesis: The Effect of Adipose Derived Mesenchymal Stem Cell and Running Exercise On The Biomechanical Properties of Partially Injured Achilles Tendon of Rat, University, (Internal Examiner)
  3. (2022) Optineurin-Mediated Mitophagy as a Potential Therapeutic Target for Intervertebral Disc Degeneration., International, (Reviewer)
  4. (2022) Platelet Derived Growth Factor Promotes The Recovery of Traumatic Brain Injury by Inhibiting Endoplasmic Reticulum Stress and Autophagy-Mediated Pyroptosis, International, (Reviewer)
Contribution to event
  1. (2022) Judge for Oral Presenters, International, (Event Organiser)
  2. (2022) Keynote Speaker, International, (Participant)

SUPERVISION


Postgraduate Student
  1. (2023) UNCOVER THE POTENTIAL ROLE OF SILENCING ACSL4 AND LPCAT3 IN INDUCED FERROPTOSIS CHONDROCYTES IN OBESE PATIENTS WITH OSTEOARTHRITIS, MOHAMMEDARFAT N K ALAMASSI
  2. (2023) THE STUDY INVESTIGATING THE EFFECTS OF TUMOR NECROSIS FACTOR ACTIVATED NF-KAPPAB PATHWAY ATTENUATION BY SILENCING RNF216/TRIAD3-E3 LIGASE IN MACROPHAGE ANTI-INFLAMMATORY PHENOTYPIC COMMITMENTS AS A POTENTIAL TREATMENT FOR INFLAMMATORY ARTHRITIS, CHOWDHURY FORHADUL KARIM
  3. (2023) INVESTIGATING THE EFFECT OF SERETOME FROM ROXADUSTAT PRECONDITIONED WHARTON JELLY-DERIVED STEM CELLS ON OXIDATIVE STRESS-INDUCED IMPAIRED VIABILITY AND CHONDROGENIC GENE EXPRESSION IN NUCLEUS PULPOSUS CELLS, SZE WEI YEOW
  4. (2023) EFFECTS OF THE HUMAN PLATELET-RICH PLASMA, PLATELET-DERIVED EXTRACELLULAR VESICLES AND PLATELET LYSATE ON THE EXPANDED OSTEOARTHRITIC CHONDROCYTES., ANAND CHANDRASEKARAN

TEACHING


Master
  1. (2022) MOB7004 - Advanced Regenerative Medicine